Tempus AI, Inc. TEM revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Tempus AI, Inc. reported revenue across 5 products and services; the largest, Diagnostics, was $955M (+111.5% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Diagnostics$955Mshare n/a+111.5% yoy
- Data And Applications$316Mshare n/a+30.9% yoy
- Insights Product$258Mshare n/a+38.0% yoy
- Trials Product$38.5Mshare n/a-9.2% yoy
- AI Applications$20.1Mshare n/a+63.4% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Diagnostics$289Mshare n/a+19.6% yoy
- Data And Applications$93.2Mshare n/a+28.0% yoy
- Insights Product$77.7Mshare n/a+35.8% yoy
- Trials Product$9Mshare n/a-8.2% yoy
- Next Product$6.3Mshare n/a+10.5% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.